FUTURE MEDICINE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,195 KRW | +3.06% |
|
+14.72% | -53.49% |
| 2022 | Future Medicine Co., Ltd. has withdrawn its IPO. | CI |
| 2021 | Future Medicine Co., Ltd. has filed an IPO. | CI |
| 1 day | +3.06% | ||
| 1 week | +14.72% | ||
| Current month | +40.13% | ||
| 1 month | +40.75% | ||
| 3 months | -26.89% | ||
| 6 months | -52.17% | ||
| Current year | -53.49% |
1 week
2 640.00
3 300.00
1 month
1 940.003 300.00
Current year
1 940.008 410.00
1 year
1 940.008 960.00
3 years
1 940.0011 400.00
5 years
1 940.0011 400.00
10 years
1 940.0011 400.00
| Managers | Title | Age | Since |
|---|---|---|---|
Wan-Seok Jeong
CEO | Chief Executive Officer | 51 | - |
Nak-Shin Jeong
CEO | Chief Executive Officer | 63 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sang-Guk Lee
BRD | Director/Board Member | 62 | 30/06/17 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/07/24 | 3,195 | +3.06% | 2,725 |
| 12/07/24 | 3,100 | +0.65% | 1,403 |
| 11/07/24 | 3,080 | +12.00% | 4,866 |
| 10/07/24 | 2,750 | +2.80% | 5,820 |
| 09/07/24 | 2,675 | -3.95% | 4,400 |
End-of-day quote Korea S.E., July 14, 2024
More quotes
Future Medicine Co Ltd is a Korea-based company mainly engaged in the synthetic drug development business. The Company is engaged in the development and sale of anti-inflammatory and anti-fibrotic agents, targeted anticancer drugs, immune anticancer drugs, metabolic cancer drugs, autoimmune diseases and targeted anticancer drugs, antiviral and other products.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -53.49% | 21.44M | |
| +25.95% | 45.54B | |
| +34.35% | 24.51B | |
| +26.79% | 16.48B | |
| +21.65% | 14.66B | |
| +73.24% | 14.3B | |
| -0.05% | 6.79B | |
| -11.59% | 6.73B | |
| +18.15% | 5.87B | |
| -8.87% | 5.73B |
- Stock Market
- Equities
- A341170 Stock
